Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
23 janv. 2024 09h00 HE
|
Baylor Genetics
Showcase Presentation to Include Case Examples from NIH’s Undiagnosed Diseases Network (UDN)
Newborn Metabolic Screening Market Size is Projected to Grow from US$ 295.7 Million in 2022 to US$ 757.9 Million by 2032, Exhibiting a CAGR of 8.9% | Persistence Market Research
22 janv. 2024 03h15 HE
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newborn Metabolic Screening Market Overview: The Newborn Metabolic Screening Market is a crucial component of newborn healthcare, aimed at detecting...
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
03 janv. 2024 10h00 HE
|
Baylor Genetics
Company Expands Test Offerings, Lab Technology, and Customer-Centric Tools Rapid Comprehensive Whole Genome and Exome Sequencing, Disease-Specific Panels and Customizable Solutions Advance Diagnoses...
Understanding Resilience to Schizophrenia through Genetics - A Free Webinar from the Brain & Behavior Research Foundation
05 déc. 2023 10h45 HE
|
Brain & Behavior Research Foundation
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Understanding Resilience to Schizophrenia through Genetics” on Tuesday,...
RNA Based Therapeutics Market Is Projected to Gain $25,121.95 Million by 2030: Allied Market Research
15 nov. 2023 10h42 HE
|
Allied Market Research
Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)),...
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
02 oct. 2023 10h00 HE
|
Baylor Genetics
Baylor Genetics to present at three top genetic conferences on WES, WGS, carrier screening and non-invasive prenatal testing
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
12 sept. 2023 08h00 HE
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
Carrier Screening Market to accrue USD 6 billion by 2032, Says Graphical Research Powered by GMI
11 juin 2023 21h00 HE
|
Graphical Research
Selbyville, Delaware, June 11, 2023 (GLOBE NEWSWIRE) -- Carrier Screening Market size is slated to reach USD 6 billion by 2032. Growing demand for personalized medicine will act as a major factor...
Viral Vector Production Market to Reach USD 17.3 Bn by 2031, growing at a CAGR of 4.4%: as per TMR Study
09 mai 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 09, 2023 (GLOBE NEWSWIRE) -- The global viral vector production market stood at USD 16.7 Bn in 2022 and is anticipated to exceed USD 17.3 Bn by 2031,...
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
28 févr. 2023 08h28 HE
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...